Table 2. Prevalence of single and multiple infections with HPV16, 18 and other HR-HPV types by age group and cytology result.
|
HPV16
|
HPV18 not 16
|
HPV16 and/or 18
|
hc2 positive
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of women | Single HR-HPV n (%) | Multiple HR-HPV n (%) | Single HR-HPV n (%) | Multiple HR-HPV n (%) | No other HR n (%) | Other HR n (%) | HR-HPV, not 16/18 n (%) | HR-HPV n (%) | No HR HPV n (%) | hc2 negative n (%) | |
| Age | |||||||||||
| 20–29 | 5150 | 280 (5.4) | 219 (4.3) | 77 (1.5) | 78 (1.5) | 374 (7.3) | 280 (5.4) | 750 (14.6) | 1404 (27.3) | 329 (6.4) | 3417 (66.3) |
| 30–39 | 7599 | 158 (2.1) | 49 (0.6) | 65 (0.9) | 17 (0.2) | 225 (3.0) | 64 (0.8) | 490 (6.5) | 779 (10.3) | 368 (4.8) | 6452 (84.9) |
| 40–49 | 6111 | 51 (0.8) | 11 (0.2) | 15 (0.2) | 3 (0.1) | 68 (1.1) | 12 (0.2) | 179 (2.9) | 259 (4.2) | 270 (4.4) | 5582 (91.3) |
| 50–64 | 5610 | 27 (0.5) | 10 (0.2) | 14 (0.2) | 3 (0.05) | 43 (0.8) | 11 (0.2) | 88 (1.6) | 142 (2.5) | 222 (4.0) | 5246 (93.5) |
| Cytology | |||||||||||
| Negative | 21 364 | 235 (1.1) | 85 (0.4) | 96 (0.5) | 47 (0.2) | 340 (1.6) | 123 (0.6) | 807 (3.8) | 1270 (6.0) | 940 (4.4) | 19 154 (89.7) |
| B/M | 2650 | 146 (5.5) | 131 (4.9) | 53 (2.0) | 41 (1.6) | 210 (7.9) | 161 (6.1) | 547 (20.6) | 918 (34.6) | 235 (8.9) | 1497 (56.5) |
| Mod+ | 456 | 135 (29.6) | 73 (16.0) | 22 (4.8) | 13 (2.9) | 160 (35.1) | 83 (18.2) | 153 (33.6) | 396 (86.8) | 14 (3.1) | 46 (10.1) |
| Total | 24 470 | 516 (2.1) | 289 (1.2) | 171 (0.7) | 101 (0.4) | 710 (2.9) | 367 (1.5) | 1507 (6.2) | 2584 (10.6) | 1189 (4.9) | 20 697 (84.6) |
B/M=borderline/mild dyskaryosis; HR-HPV=high-risk human papillomavirus; Mod+=moderate dyskaryosis or worse.